AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

The boss of drugmaker AstraZeneca has said he was “very disappointed” with the firm’s move to scrap plans for a £450 million ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Whitehall editor Kate Devlin question why ...

AstraZeneca has halted plans to build a £450 million vaccine plant in the UK due to decreased government support, prompting ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

AstraZeneca have not stated plans for an alternative. An FT report meanwhile said that vaccines were “off strategy” for AstraZeneca, suggesting “figures on both sides of the negotiations hav ...

The boss of drugmaker AstraZeneca has said he was ‘very disappointed’ with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, but insisted the business case did ...

The pharmaceutical giant announced its decision to cancel its planned investment just two days after Chancellor Rachel Reeves ...

AstraZeneca's chief, Pascal Soriot, has said he is "very disappointed" after scapping plans for a £450m vaccine plant in Liverpool, but stressed that the numbers just didn't add up. The CEO of ...

The U.K. government is defending its negotiations with AstraZeneca (AZN), after the pharmaceutical company dropped a planned $558M investment ...

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 billion. However many analysts felt the company had paid far too much ...